You can buy delta-8 at Target. A WNBA player can’t touch it.
Target is launching hemp THC drink sales in three of the most populous states in the country. You can walk into a big-box retailer in Minnesota and buy a THC beverage next to the cold brew. But if you play professional basketball, that shelf is now contractually off-limits.
Because here’s the sentence nobody put on the press release: the same WNBA collective bargaining agreement that freed cannabis banned synthetic cannabinoids and specifically named delta-8 THC as an example.
Let that sit. A publicly traded retailer with 400,000 employees looked at the hemp market and said sure. A sports league looked at the same market and wrote it into a ban — in 2026, while the White House is actively pushing Congress to keep hemp CBD products legal.
To be clear: the WNBA has every right to ban whatever it wants. This is a private labor agreement, not a statute, and nobody’s constitutional rights are on the line. The problem isn’t the league’s authority — it’s the league’s reasoning. If a product is regulated enough for a Fortune 50 retailer to sell it in broad daylight, “dangerous substance” is a hard case to make in a document you just signed. The WNBA didn’t have to justify the delta-8 ban. It just didn’t bother.
That’s the story. The WNBA marijuana policy win is real, but it came stapled to four more prohibitions and a hemp ban aimed at products your average adult can buy at Target.
What Actually Changed on Cannabis
The long-form CBA got signed May 22, 2026. Marijuana is off the prohibited substances list. Under the prior deal it sat under “Drugs of Abuse” — right there with the hard stuff.
Good. It’s about damn time. The old WNBA drug testing regime was harsher on weed than the NBA’s, and harsher than a growing list of leagues that already figured this out. First offense got you a treatment referral. Keep testing dirty and you were looking at fines and suspensions. For a plant that’s legal for adults in most of the country.
Now there’s no routine cannabis testing for athletes. But the league carved out three ways to still put you in a cup:
- You’re already in the Drugs of Abuse Program
- You’re under the influence during team or league activities
- The league decides you have “a dependency or other related issue”
That third one is a barn door. “Dependency or other related issue” is exactly the kind of language that means whatever the person holding the clipboard wants it to mean.
And once you’re in a treatment program, the meter starts running. Don’t comply, that’s $300 a day. Show a “mindful disregard” for your treatment responsibilities or pop positive, and you’re looking at a $3,000 fine or a three-game suspension — or worse. Get convicted of a felony involving marijuana distribution and you’re back to reasonable-cause testing and administrative proceedings.
So it’s not decriminalized inside the league. It’s more like a speeding ticket that only gets written if a cop decides he doesn’t like your face.
The WNBA Delta-8 Ban and the Psychedelics Trade
The delta-8 THC ban didn’t travel alone. The same document added DMT, ibogaine, psilocybin, and psilocin to the prohibited list — for the first time ever.
Read that again. These substances weren’t banned before. The WNBA went out of its way to ban them in 2026, while the FDA is running trials, while Connecticut is expanding a psychedelics pilot program in preparation for federal approval, while the VA is studying MDMA for veterans with PTSD.
Ibogaine is being studied for opioid dependence. Psilocybin is in late-stage trials for treatment-resistant depression. Professional athletes — who deal with chronic pain, head trauma, and the mental health load of a brutal schedule — just got told those doors are closed before they ever opened.
The philosophy never changed. Only the target list did.
The Money Rules: You Can Own It, You Just Can’t Run It
Players can now hold ownership in marijuana companies. With conditions:
- Passive only. No management, no governance, no voting, no executive role, no operational anything.
- Under 50 percent. You can’t control it.
- Fully compliant operators only.
- And here’s the kicker: no ownership in any business producing or selling a Prohibited Substance or any Schedule I or II substance under the CSA.
Here’s the legal backdrop. The Trump administration announced in April that it’s moving state-licensed medical cannabis — plus FDA-approved cannabinoid products — to Schedule III. Schedule III would put those businesses outside the WNBA’s prohibition language. Adult-use cannabis? Still Schedule I. A broader cannabis rescheduling hearing is on the calendar, and we’ve been tracking the legalization fight state by state the whole way.
TNM OPINION: Stack those two facts and here’s our read — a WNBA player’s investment portfolio is now legally contingent on a DEA proceeding. The league wrote a rule whose practical meaning could shift depending on what a federal agency does next. The CBA doesn’t say that, and neither the league nor the union has addressed it. That’s our analysis, not their language. But somebody’s lawyer is going to have to answer the question eventually.
CBD Endorsement Rules: Easy Ride Until It Touches Weed
The CBD endorsement rules are looser: no passive requirement, no 50 percent cap. Players can actively promote and endorse CBD brands.
Then the wall goes up. If a marijuana company makes the CBD product, the player needs approval from both the league and the union. Even with approval, the endorsement dies if the CBD product is associated with a marijuana product — same brand, same shelf — or if the promotion creates a “reasonable risk of public confusion.”
Translation: you can sell wellness, but the plant is not invited to the photo shoot. Cannabis is fine as long as it’s laundered through a lifestyle brand that never says the word.
And if a player screws it up? The CBA says she must dump her ownership interest and kill the endorsement immediately — no grace period.
The irony is thick, because CBD for athletes is the one place the sports establishment already caved. The NFL is partnering with researchers on CBD for concussions and pain management — the league with the worst head-trauma record in American sports decided the cannabinoid was worth studying. The WNBA will let you sell it. Just don’t let anyone see the plant it came from.
The Griner Shadow
You can’t write about the WNBA and weed without Brittney Griner. She did time in a Russian prison over cannabis possession — a case that dragged international drug policy hypocrisy into the daylight and made cannabis prohibition a mainstream American conversation. Last year she pulled out of a cannabis event appearance after finding what she considered a threatening message in her hotel room. Attendees had come to hear her talk about the incarceration itself.
The league that employed her spent years testing her peers for the same plant that put her in a penal colony. That policy is finally gone. It took way too long, and the WNBA doesn’t get a parade for arriving last.
The League Was Late and Everyone Knows It
The receipts on marijuana reform in professional sports:
- NBA — dropped weed from its banned list in 2023, and let players invest in and promote cannabis companies. And the league had already stopped testing players for marijuana for three straight seasons before it ever made the policy official — the WNBA’s own corporate sibling proved the sky doesn’t fall
- NCAA — removed marijuana for Division I athletes in 2024, building on a 2022 THC threshold increase that aligned with WADA
- NFL — reformed again in 2024: lower fines, higher THC threshold — years after ending drug suspensions entirely
- UFC — dropped it in late 2023, then had to warn fighters that California’s athletic commission didn’t care
- Nevada — adopted a rule in 2024 protecting boxers and MMA fighters using cannabis legally under state law
Then there’s the WADA cannabis ban, which is its own monument to bad reasoning. WADA dropped CBD from its banned list back in 2017 — but kept THC, on the theory that it meets the criteria for prohibition: performance enhancement, health risk, or violating “the spirit of the sport.” A substance needs to hit two of three.
Here’s the thing: none of those three are proven. Research out of the University of Colorado Boulder found cannabis doesn’t improve performance times or accuracy — it just makes exercise feel easier. That’s not performance enhancement. That’s vibes.
USADA CEO Travis Tygart has said the quiet part out loud: he called the ban “disappointing” and told Yahoo Sports his agency isn’t in the recreational drug policing business — they’re there to prevent cheating. WADA reviewed the policy anyway, after Sha’Carri Richardson got barred from the 2021 Olympics over a THC test. She’d used cannabis after her mother died. WADA kept the ban.
The WNBA showed its hand back in 2024, when the New York Liberty partnered with a CBD beverage company. The money was already comfortable. The policy just took two more years to catch up.
The Bottom Line
This is a real win. Women who play professional basketball in a country where most adults can legally buy cannabis will no longer be fined and suspended for using it. That matters. It should have happened in 2021.
But be honest about the shape of it. The WNBA didn’t decide prohibition is wrong. It decided this particular prohibition had become indefensible — while adding five new ones on the way out the door. Delta-8 is legal enough for Target. Psilocybin is legal enough for the FDA to study. Neither is legal enough for a WNBA player.
Freedom with a fine schedule attached is a compromise, not a principle. Take the win. Just don’t confuse it with respect.
For more on how federal policy keeps colliding with the cannabis industry, follow our U.S. cannabis news coverage and cannabis business reporting.
